The fossilized skull of a marine reptile called an ichthyosaur is now being studied after being found in B.C.'s Kiskatinaw River valley, roughly 52 kilometres south of Fort St. John. Local resident ...
No Windsor Castle or banquets but the latest visit by a high-profile American to England is now far more significant to Norwich City fans. The club’s principal owner, Mark Attanasio, is due in Norfolk ...
The cervical disc replacement landscape just got a major upgrade. The FDA has officially granted premarket approval (PMA) for two-level indications for not one, but two total disc replacement (TDR) ...
All metal fans have heard that tedious comment when playing your favourite music to a non-metalhead: “It’s just shouting! Anyone could do that!” Au contraire, my normie chum! Being a great metal ...
The Faculty of Arts and Sciences slashed the number of Ph.D. student admissions slots for the Science division by more than 75 percent and for the Arts & Humanities division by about 60 percent for ...
Two Albanian nationals were sentenced to six months imprisonment after admitting to using false passports at the Malta International Airport. The men, identified as Klaudjo Gjini and Mustafa Sadikaj, ...
Roughly 42 million people are at risk of losing critical food assistance in November amid the federal government shutdown. And it’s not clear whether the Trump administration will step in to find the ...
Manitoba’s Merit-Based Program funds projects that reduce greenhouse gas emissions, including transitions from the combustion of fossil fuels to renewable energy within the province. Manitoba’s ...
Oct 16 (Reuters) - Nearly two dozen states are suing the Trump administration over its cancellation of a $7 billion grant program aimed at expanding solar energy in low-income communities, according ...
Production unexpectedly shook things up on the latest episode of "Survivor" season 49. During episode 4, "Go Kick Rocks, Bro," which aired Wednesday, Oct. 15, host Jeff Probst announced a tribal swap ...
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback